Zebrafish Depression and Anxiety Models

Introduction Model Details Phenotypic Evaluation Applications Study Examples

Introduction

Depression and anxiety disorders are among the most prevalent neuropsychiatric conditions worldwide. Major depressive disorder is characterized by persistent low mood, anhedonia, fatigue, changes in appetite and sleep, psychomotor alterations, and cognitive impairment. Anxiety disorders encompass generalized anxiety, panic disorder, social anxiety, and specific phobias, with core features of excessive fear, worry, avoidance, and heightened physiological arousal. These conditions frequently co-occur and contribute substantially to global disability, reduced quality of life, and increased risk of suicide. Both genetic predisposition and environmental factors, including chronic stress and early life adversity, are implicated in pathogenesis.

Current pharmacotherapy with selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors, and other agents can be effective, but many patients exhibit treatment resistance, delayed onset of therapeutic action, or intolerable side effects. Key research challenges include identifying novel molecular targets, understanding the neurobiology of stress resilience versus vulnerability, and developing compounds with faster onset and improved efficacy. Zebrafish are increasingly used to model depression- and anxiety-related states because stress-responsive neuroendocrine systems, monoaminergic neurotransmitter pathways, and the hypothalamic–pituitary–interrenal axis are conserved. Behavioral assays in zebrafish enable rapid, reproducible, and scalable assessment of anxiety-like and depression-like phenotypes.

Why Zebrafish?

Conserved Pathways: Stress-responsive neuroendocrine and monoaminergic pathways are conserved in zebrafish.
Anxiety Assays: Novel tank, scototaxis, and social behavior assays reliably measure anxiety-like phenotypes.
Chronic Stress Paradigms: Chronic stress paradigms induce quantifiable depression-like behavioral and neurochemical changes.
Rapid Screening: Behavioral models support rapid compound screening for anxiolytic and antidepressant activity.

Available Zebrafish Disease Models

Our zebrafish behavioral platform covers chronic stress, developmental isolation, acute anxiety, and pharmacological induction models:

Model Name	Induction Method	Features
Chronic Unpredictable Stress (CUS) / Chronic Mild Stress (CMS) Model	Adult zebrafish are exposed to a series of unpredictable, varied mild stressors, such as water changes, net chasing, low water depth, overcrowding, or temperature shifts, typically delivered twice daily over 7–14 days.	Most established zebrafish depression-like model; suitable for studying anxiety-related behavior, reduced exploration, anhedonia-like phenotypes, neuroendocrine dysregulation, and antidepressant drug effects.
Developmental Social Isolation Model	Zebrafish are raised in isolation from early developmental stages through adulthood, depriving them of normal social interactions.	Models early-life stress effects on adult behavior; useful for studying social withdrawal, altered stress reactivity, and neurochemical changes associated with depression vulnerability.
Novel Tank Diving Test (Acute Anxiety Model)	Naïve adult zebrafish are placed in a novel tank; anxiety-like behavior is assessed by measuring time spent at the bottom of the tank, reduced exploration, erratic movement, and freezing.	Most widely used acute anxiety assay in zebrafish; suitable for rapid anxiolytic and anxiogenic compound screening, and evaluation of stress-induced anxiety-like phenotypes.
Pharmacological Anxiety / Depression Induction Model	Acute or subacute exposure to anxiogenic compounds such as caffeine, or chronic withdrawal from ethanol or other substances, to induce anxiety-like or depression-like states.	Useful for mechanism-specific studies and for evaluating pharmacological rescue by anxiolytic or antidepressant candidates.

Phenotypic Evaluation

Neurochemical and Molecular Validation

Brain monoamine levels and turnover
Serotonergic and dopaminergic pathway gene expression
Neurotrophic factor expression
Inflammatory and oxidative stress markers
Neurogenesis-related markers

Depression-Related Behavioral Endpoints

Exploration and locomotor activity
Total distance traveled
Time spent stationary
Response to social stimuli
Anhedonia-like measures

Neuroendocrine and Stress Markers

Whole-body cortisol levels
Hypothalamic–pituitary–interrenal axis gene expression
Cortisol response to acute stress
Stress recovery dynamics

Anxiety-Related Behavioral Endpoints

Time spent in the bottom third of a novel tank
Latency to enter the top zone
Freezing duration
Erratic movement frequency
Thigmotaxis in an open arena

Key Applications

Anxiolytic and Antidepressant Screening: Evaluate whether test compounds reduce anxiety-like behavior, increase exploration, normalize stress-induced behavioral changes, or restore altered neurochemical profiles.
Stress Neurobiology and Resilience: Investigate mechanisms underlying individual differences in stress susceptibility, resilience, and the neuroendocrine response to chronic stress.
Target Validation: Assess candidate genes, receptors, or signaling pathways involved in stress-related disorders, including monoaminergic, neurotrophic, and inflammatory pathways.
Early-Life Stress Studies: Examine how developmental isolation or early stress exposure produces lasting behavioral and neurochemical changes relevant to depression and anxiety vulnerability.
Behavioral Phenotyping: Use acute anxiety assays and chronic stress models to rapidly prioritize compounds with potential CNS activity before advancing to mammalian studies.

Study Examples

Developmental isolation combined with unpredictable chronic mild stress models depression-like behavior. This study investigated the combined effects of developmental social isolation and unpredictable chronic mild stress on zebrafish behavior and neurochemistry. The authors found that UCMS increased anxiety-like behavioral responses, while developmental isolation altered motor responses. UCMS diminished weight gain and reduced whole-brain levels of dopamine and serotonin’s metabolite 5-HIAA specifically in developmentally isolated fish, but not in socially reared animals, revealing vulnerability and resilience.

Fig. 1. Combined developmental isolation and unpredictable chronic mild stress reduce brain monoamine levels and alter behavior in zebrafish (Fulcher N, Tran S, et al., 2016).

An unpredictable chronic stress protocol induces anxiety-like and depression-like behavior in zebrafish. The authors adapted the unpredictable chronic stress paradigm for adult zebrafish. Fish were exposed to a variety of stressors delivered twice daily over 7 or 14 days, including crowding, water changes, low water, and chasing. Stress-exposed fish showed increased anxiety-like behavior in the novel tank test, including reduced time in the top zone and increased freezing. Whole-body cortisol levels were elevated, and brain oxidative stress markers were altered.

Fig. 2. Unpredictable chronic stress increases anxiety-like behavior and reduces exploration in the novel tank test (Piato AL, Capiotti KM, et al., 2010).

Depression and Anxiety Disorders Research with Zebrafish Models

Advance your mood and anxiety disorder research with zebrafish behavioral models tailored to your study goals. Contact us to discuss a zebrafish study plan for your target, pathway, or therapeutic candidate.

Contact Our Scientists

References

Fulcher N, Tran S, et al. Neurochemical and behavioral responses to unpredictable chronic mild stress following developmental isolation: the zebrafish as a model for major depression. Zebrafish 14(1), 23–34 (2017).
Piato AL, Capiotti KM, et al. Unpredictable chronic stress model in zebrafish (Danio rerio): behavioral and physiological responses. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35(2), 561–567 (2011).

For research use only. Not intended for any clinical use.